STOCK TITAN

IGC Pharma (IGC) Revenue by Year

IGC NYSE

IGC Pharma, Inc. generated $1.3M in revenue in fiscal year 2025. This represents a decrease of 5.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters IGC Pharma, Inc. has filed alongside them.

FY2025 annual
Revenue $1.3M
YoY -5.5%
5Y CAGR -20.8%
10Y CAGR -16.5%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

IGC Revenue by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KTFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$1.3M-5.5%$1.3M+47.6%$911K+129.5%$397K-55.8%$898K-77.9%$4.1M-20.4%$5.1M+133.3%$2.2M+277.9%$580K-90.9%$6.4M-17.1%$7.7M+237.9%$2.3M-71.7%$8.0M+91.2%$4.2M+3.1%$4.1M

IGC Revenue by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KTQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$328K+27.6%$265K-35.7%$317K+16.5%N/A$191K-53.6%$328K+20.6%$330K+11.9%$257K+26.0%$412K+41.6%$272K-51.0%$295K+78.8%$204K-38.6%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More IGC Pharma, Inc. financials

Frequently Asked Questions

IGC Pharma, Inc. generated $1.3M in revenue in fiscal year 2025.

IGC Pharma, Inc. (IGC) revenue fell by 5.5% year over year, from $1.3M to $1.3M in fiscal year 2025.

Across the 15 fiscal years this page covers, IGC Pharma, Inc. (IGC) revenue went from $4.1M in fiscal year 2011 to $1.3M in fiscal year 2025.

IGC Pharma, Inc. (IGC) reported $328K in revenue in Q3 2026. This represents an increase of 27.6% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what IGC Pharma, Inc. (IGC) reported on that line in every period on record.